May 13 |
Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates
|
May 13 |
Verrica Pharmaceuticals Non-GAAP EPS of -$0.38 beats by $0.06, revenue of $3.83M beats by $1.18M
|
May 13 |
Verrica Pharmaceuticals Reports First Quarter 2024 Financial Results
|
May 9 |
Verrica Pharmaceuticals to Present at Upcoming Investor Conferences
|
May 8 |
Verrica Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 13, 2024
|
May 6 |
Verrica Pharmaceuticals (VRCA) Moves 7.4% Higher: Will This Strength Last?
|
Apr 25 |
Strength Seen in Amneal (AMRX): Can Its 12.0% Jump Turn into More Strength?
|
Apr 3 |
Strong week for Verrica Pharmaceuticals (NASDAQ:VRCA) shareholders doesn't alleviate pain of three-year loss
|
Apr 2 |
Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 26 |
Verrica Pharma gains as FDA lists Ycanth in Orange Book
|